11331329

Source:http://linkedlifedata.com/resource/pubmed/id/11331329

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001554, umls-concept:C0030705, umls-concept:C0302995, umls-concept:C0439234, umls-concept:C0596545, umls-concept:C0872169, umls-concept:C1273870, umls-concept:C2347782
pubmed:issue	9
pubmed:dateCreated	2001-5-1
pubmed:abstractText	To measure the impact of whole-body fluorodeoxyglucose (FDG) positron emission tomography (PET) on patient management during its first year of use in a community hospital.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fluorodeoxyglucose F18
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0732-183X
pubmed:author	pubmed-author:CoenKK, pubmed-author:DrugerGG, pubmed-author:LUGG, pubmed-author:McGuiganPP, pubmed-author:MorrisPP, pubmed-author:TuckerRR
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	19
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2504-8
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11331329-Fluorodeoxyglucose F18, pubmed-meshheading:11331329-Humans, pubmed-meshheading:11331329-Neoplasms, pubmed-meshheading:11331329-Tomography, Emission-Computed
pubmed:year	2001
pubmed:articleTitle	Impact of fluorine-18 fluorodeoxyglucose positron emission tomography on patient management: first year's experience in a clinical center.
pubmed:affiliation	Hamamatsu/Queen's Positron Emission Tomography Imaging Center, Queen's Medical Center, Honolulu, HI 96813, USA. trobertv@aol.com
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't